Is ARSMX or JNJ a better dividend investment in 2026?

ARSMX currently yields 5.09% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ARSMX offers higher current income.

What is the dividend yield difference between ARSMX and JNJ?

ARSMX has a forward dividend yield of 5.09% ($0.47/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 1.73 percentage points.

Home › Compare › ARSMX vs JNJ

ARSMX vs JNJ: Dividend Comparison 2026

ARSMX yields 5.09% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARSMX wins by $7.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ARSMX

● Live price

5.09%

Share price

$9.24

Annual div

$0.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.9K

Annual income

$705.18

Full ARSMX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ARSMX vs JNJ

📍 ARSMX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ARSMX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ARSMX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ARSMX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARSMX

Annual income on $10K today (after 15% tax)

$432.82/yr

After 10yr DRIP, annual income (after tax)

$599.40/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $104.21/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARSMX + JNJ for your $10,000?

ARSMX: 50%JNJ: 50%

100% JNJ50/50100% ARSMX

Portfolio after 10yr

$24.0K

Annual income

$766.48/yr

Blended yield

3.20%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ARSMX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARSMX buys

JNJ buys

No recent congressional trades found for ARSMX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricARSMXJNJ

Forward yield	5.09% ✓	3.36%
Annual dividend / share	$0.47	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$27.9K ✓	$20.0K
Annual income after 10y	$705.18	$827.78 ✓
Total dividends collected	$6.1K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ARSMX vs JNJ ($10,000, DRIP)

Year	ARSMX Portfolio	ARSMX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,209	$509.20	$10,676	$355.77	+$533.00 → ARSMX
2	$12,527	$533.43	$11,407	$389.39	+$1.1K → ARSMX
3	$13,961	$557.16	$12,198	$426.53	+$1.8K → ARSMX
4	$15,519	$580.31	$13,056	$467.62	+$2.5K → ARSMX
5	$17,208	$602.86	$13,987	$513.12	+$3.2K → ARSMX
6	$19,037	$624.74	$14,998	$563.56	+$4.0K → ARSMX
7	$21,016	$645.94	$16,098	$619.52	+$4.9K → ARSMX
8	$23,154	$666.43	$17,295	$681.69	+$5.9K → ARSMX
9	$25,460	$686.18	$18,599	$750.82	+$6.9K → ARSMX
10	$27,948	$705.18	$20,022	$827.78	+$7.9K → ARSMX

ARSMX vs JNJ: Complete Analysis 2026

ARSMX — Stock

The fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity securities of small- and mid-capitalization companies that the subadviser believes are undervalued. The subadviser considers small- and mid-capitalization companies to be those with market capitalizations at the time of acquisition within the range of capitalizations of companies in the Russell 2500™ Index. Value investing involves buying stocks that the subadviser believes are out of favor and/or undervalued in comparison to their peers or their prospects for growth.

Full ARSMX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ARSMX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARSMX vs SCHD ARSMX vs JEPI ARSMX vs O ARSMX vs KO ARSMX vs MAIN ARSMX vs ABBV ARSMX vs MRK ARSMX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.